Analysis found that 38% of the credits - equivalent to 73 million tonnes of CO2 - were over five years old, while more than 4% were at least 10 years old

The industry was beset by a liquidity crunch in the past year and only a few companies expressed interest in joining the Test & Go programme

Sintilimab, made by Suzhou-based Innovent and US drugmaker Eli Lilly, has been developed and commercialised under a global agreement

Hong Kong's daily Covid infections nearly doubled to a record 1,161 cases on Wednesday as the global financial hub battles a rapid surge

Tourists from about 150 territories allowed to visit the Philippines visa-free will be able to enter for the first time in nearly two years

Anthony Fauci said US was leaving a "full-blown" pandemic behind, while drugmaker Pfizer forecast more than $50 billion in 2022 sales

Continuing restrictions may prolong supply chain disruptions and global inflationary pressures, says Bank of Japan board member Toyoaki Nakamura

Bank reports a half-year profit of A$4.7 billion, announces an interim dividend of A$1.75 per share

Shares of WuXi Biologics plunge 25% after Commerce Dept adds 33 Chinese entities to its 'unverified list', which requires exporters to go through more procedures before shipping goods

Lam was set to announce further Covid restrictions later in the day after the city saw a "shocking" new record of over 600 infections on Monday

Government blames a resurgence of Covid-19 for a drop in deliveries of fresh produce from the mainland, as truck drivers were reportedly found to have the virus

Chinese scientists and health specialists stress the need for stringent controls, saying transmission risks are too high and that mass infection would put intolerable pressure on health systems